Australian Clinical Labs (ACL) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free ACL Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | msn.comThe ACL Cross Bracing Protocol healed my torn ligament. This is how it worksApril 18, 2024 | morningstar.comAustralian Clinical Labs LtdApril 2, 2024 | au.news.yahoo.comTruth Social made 1000 times less money than X last yearMarch 31, 2024 | sg.finance.yahoo.comIs It Too Late To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?March 27, 2024 | au.investing.comASX 200 adds 0.8% as S&P 500 resets record valuationsFebruary 18, 2024 | au.lifestyle.yahoo.comWith Twilio under activist pressure, Segment could be put up for saleFebruary 16, 2024 | finance.yahoo.comIs Australian Clinical Labs Limited's (ASX:ACL) Latest Stock Performance A Reflection Of Its Financial Health?January 20, 2024 | uk.finance.yahoo.comIs There An Opportunity With Australian Clinical Labs Limited's (ASX:ACL) 36% Undervaluation?January 11, 2024 | afr.comWhy this fundie is backing ACL, Ramsay and DexusDecember 14, 2023 | msn.comHealius shares tumble as Australian Clinical Labs intends to withdraw $1 billion offerDecember 14, 2023 | msn.comAustralian Clinical Labs to withdraw $1 billion offer for Healius; stocks fallDecember 14, 2023 | afr.comACL pulls Healius bid as ACCC blocks pathology shake-upDecember 14, 2023 | news.yahoo.comAustralian regulator kills ACL's $1 billion bid for rival HealiusDecember 14, 2023 | ca.finance.yahoo.comAustralian Clinical Labs to withdraw its $1 billion offer to buy HealiusDecember 14, 2023 | marketwatch.comAustralian Clinical Labs Withdraws Takeover Offer for HealiusDecember 14, 2023 | reuters.comAustralian Clinical Labs to withdraw its $1 bln offer to buy HealiusNovember 29, 2023 | theguardian.comMedical test company’s ‘serious and systemic failures’ led to cyber-attack, watchdog saysNovember 28, 2023 | afr.comSexual health and fertility details leaked in ACL data breachNovember 23, 2023 | afr.comACL accuses Wylie of hiding links to independent Healius directorNovember 20, 2023 | afr.comDividend drought adds to pain for Healius shareholdersNovember 20, 2023 | afr.comHealius preps $200 million equity raising; Barrenjoey on ticketNovember 5, 2023 | fool.com.auThis ASX healthcare share just hit a 52-week low, is it time to buy?November 3, 2023 | msn.comLive: ASX jumps after Wall Street bounce, as Qantas faces shareholders and ACL faces hacking proceedingsOctober 30, 2023 | afr.comCrescent Capital claims stake in clinical trials biz WalskiOctober 23, 2023 | finance.yahoo.comWhat Does Australian Clinical Labs Limited's (ASX:ACL) Share Price Indicate?August 12, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of Australian Clinical Labs Limited (ASX:ACL)July 26, 2023 | finance.yahoo.comAustralian Clinical Labs Limited (ASX:ACL) is definitely on the radar of institutional investors who own 41% of the companyJuly 20, 2023 | afr.comPathology dream deal a three-headed competition nightmareJuly 20, 2023 | afr.comACCC inches closer to blocking $2b Healius-ACL merger proposalJuly 20, 2023 | reuters.comRegulator flags concerns on Australian Clinical's buyout offer for HealiusJuly 5, 2023 | au.finance.yahoo.comACL.AX - Australian Clinical Labs LimitedJune 16, 2023 | fool.com.auFundie reveals ASX 300 healthcare stock trading at 40% discount to peersJune 4, 2023 | afr.comWhy Nathan Parkin is betting big on small capsMay 16, 2023 | finance.yahoo.comIs Now The Time To Look At Buying Australian Clinical Labs Limited (ASX:ACL)?April 12, 2023 | finance.yahoo.comA number of insiders bought Australian Clinical Labs Limited (ASX:ACL) stock last year, which is great news for shareholdersApril 10, 2023 | afr.comCrescent Capital locks in $1b for seventh fund, CEFC cuts a chequeMarch 26, 2023 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Australian Clinical Labs Limited's ASX:ACL) Stock?March 19, 2023 | msn.comASX Health Stocks: Healius gets takeover offer from company half its sizeMarch 19, 2023 | financialpost.comAustralian Clinical Labs offers to buy Healius for $1 blnMarch 19, 2023 | afr.comOpportunistic Clinical Labs tries to pull off dream deal with HealiusMarch 19, 2023 | bloomberg.comAustralian Clinical Labs Puts $1.1 Billion Bid to HealiusMarch 19, 2023 | afr.comAustralian Clinical Labs makes play for HealiusMarch 19, 2023 | marketwatch.comAustralian Clinical Labs Makes All-Share Takeover Offer for HealiusMarch 19, 2023 | afr.comHistoric day, but a day no one wanted: UBS chairmanMarch 19, 2023 | afr.comLarge portion of UBS cost-cutting will be reducing staffMarch 3, 2023 | msn.comHow an ACL tear ended two key Vol athletes’ seasonsFebruary 16, 2023 | finance.yahoo.comAustralian Clinical Labs Limited (ASX:ACL) has caught the attention of institutional investors who hold a sizeable 35% stakeDecember 17, 2022 | finance.yahoo.comInvestors in Australian Clinical Labs (ASX:ACL) have unfortunately lost 32% over the last yearNovember 12, 2022 | afr.comAustralian Clinical Labs LimitedNovember 6, 2022 | msn.comFactbox: Australia Inc roiled by raft of cyberattacks this year Get Australian Clinical Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ACL and its competitors with MarketBeat's FREE daily newsletter. Email Address CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it. Click on Adam's shiny forehead for more details. ACL Media Mentions By Week ACL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACL News Sentiment▼0.000.42▲Average Medical News Sentiment ACL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACL Articles This Week▼00▲ACL Articles Average Week Get Australian Clinical Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ACL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: bioAffinity Technologies News Izotropic News Many Bright Ideas Technologies News Medical Imaging News Star Equity News WuXi AppTec News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:ACL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.